Zikán V, Roubal P, Stĕpán J
III. interní klinika 1. LF UK a VFN, Praha.
Cas Lek Cesk. 2002 Mar 1;141(4):127-31.
The aim of this study was to assess acute biochemical changes after the administration of two different pharmaceutical forms of calcium carbonate or milk.
The group of 12 young (aged 20-27 years) and 12 older women (aged 63-71 years). After overnight fasting, each of the volunteers received a 1 g of elemental calcium in either form of the tested preparation: powder form of calcium carbonate--Vitacalcin pulvis (Slovakofarma, SR) or effervescent tablet--Calcium 500 mg Pharmavit (Pharmavit, MR) or in 250 ml of milk enriched with the milk calcium complex. Between each test the interval of 1-2 weeks was held. Samples of blood and urine were taken in the fasting state before and during 5.5 h following ingestion of the calcium load. Both calcium carbonate and milk induced a significant increase in the serum ionised calcium (iCa) and a significant decrease in plasma parathormone level (PTH) in comparison with the baseline levels in both groups of women. Comparison between individual preparations and between preparations and milk did not reveal any significant differences in suppression of PTH. Comparison of the effects between young and elderly women did not show any statistically significant difference in any measured parameter.
Our results confirmed the good bioavailability of calcium from milk and from both calcium preparations in both age groups of women. Significantly more frequent hypercalcemia in the young women (p < 0.05) and also the slightly higher hypercalciuria occurred after the application of calcium in the pharmaceutical form of effervescent tablet than after the application of calcium in the form of powder or after the application of milk.
本研究旨在评估给予两种不同剂型的碳酸钙或牛奶后急性生化变化。
该组包括12名年轻女性(20 - 27岁)和12名老年女性(63 - 71岁)。经过一夜禁食后,每位志愿者接受1克元素钙,其形式为受试制剂:碳酸钙粉末——维它钙粉剂(斯洛伐克制药公司,斯洛伐克共和国)或泡腾片——500毫克钙 Pharmavit(Pharmavit公司,斯洛伐克共和国),或250毫升富含乳钙复合物的牛奶。每次测试之间间隔1 - 2周。在摄入钙负荷前的空腹状态以及摄入后5.5小时内采集血液和尿液样本。与两组女性的基线水平相比,碳酸钙和牛奶均导致血清离子钙(iCa)显著升高以及血浆甲状旁腺激素水平(PTH)显著降低。各制剂之间以及制剂与牛奶之间在抑制PTH方面未发现任何显著差异。年轻女性和老年女性之间的效果比较在任何测量参数上均未显示出任何统计学上的显著差异。
我们的结果证实了在两个年龄组的女性中,牛奶以及两种钙制剂中的钙具有良好的生物利用度。年轻女性中高钙血症的发生率显著更高(p < 0.05),并且与服用碳酸钙粉末或牛奶相比,服用泡腾片剂型的钙后高钙尿症也略高。